Newsroom
Sorted by: Latest
-
Advicenne Informs About the Ongoing Safeguard Procedure
PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases, today informs its shareholders that the hearing marking the end of the observation period under the safeguard proceedings will be held on November 9, 2026, before the Paris Commercial Court. Consequently, the Company will provide an update on the next step...
-
Antin Infrastructure Partners: Information on the Total Number of Shares and Voting Rights
PARIS & LONDON & NEW YORK--(BUSINESS WIRE)--Regulatory News: Antin Infrastructure Partners (Paris:ANTIN): Date 31 October 2026 Company name Antin Infrastructure Partners Trading place Euronext Paris (compartment A) ISIN FR0014005AL0 Total number of shares 179,193,288 Total number of voting rights including treasury shares 321,146,766 Total number of voting rights excluding treasury shares 319,829,554 About Antin Infrastructure Partners Antin Infrastructure Partners is a leading private equity f...
-
Advicenne : information relative à la procédure de sauvegarde
PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), société pharmaceutique spécialisée dans le développement et la commercialisation de traitements innovants pour les personnes souffrant de maladies rénales rares et de maladies neurologiques, informe aujourd’hui ses actionnaires que l’audience de fin de période d’observation dans le cadre de la procédure de sauvegarde (cf. communiqué du 5 mai 2026), se tiendra le 9 novembre 2026 devant le Tribunal de...
-
THERACLION RENFORCE SES PERSPECTIVES DE DÉVELOPPEMENT AU MOYEN-ORIENT EN OBTENANT L’AUTORISATION DE COMMERCIALISER LE SONOVEIN® EN ARABIE SAOUDITE
MALAKOFF, France--(BUSINESS WIRE)--Regulatory News: THERACLION (ISIN : FR0010120402 ; Mnémo : ALTHE), société innovante développant Sonovein®, une plateforme robotique de traitement non invasif des varices par ultrasons focalisés de haute intensité (HIFU), annonce avoir obtenu de l’autorité réglementaire saoudienne Saudi Food and Drug Authority (SFDA) l’autorisation de mise sur le marché (Medical Device Marketing Authorization) du Sonovein®. Cette autorisation permet à Theraclion de commerciali...
-
Acumatica Called Out for Industry Leadership in Customer Satisfaction, Business Impact, and Sustainability
BELLEVUE, Wash.--(BUSINESS WIRE)--Acumatica Called Out for Industry Leadership in Customer Satisfaction, Business Impact, and Sustainability...
-
Ovation Tax Group Joins Current, Bringing Tax Resolution Expertise to Its Growing Network
NORTHRIDGE, Calif.--(BUSINESS WIRE)--Ovation Tax Group, a leading tax resolution firm, announced it has joined Current, a national partnership of accounting and advisory firms....
-
ECL CSC1 35MW AI Data Center Fully Leased as Demand for Inference-Scale Colocation Outpaces Grid-Connected Development in Northern California
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--ECL today announced that CSC1, its 35MW FlexGrid-powered data center in Santa Clara, Calif., is fully committed across three tenants, with deployment beginning in Q1 2027 and completion expected by Q3/Q4 2027. The three tenants, including established AI cloud platforms and inference-focused startups backed by leading AI research organizations, are deploying AI inference workloads at CSC1. The company has simultaneously opened three additional sites, CSJ1,...
-
Traversal Raises $120M with a $1 Billion Valuation to Keep Code Running With a Superintelligent AI Site Reliability Engineer
NEW YORK--(BUSINESS WIRE)--Traversal, the frontier lab building AI agents for enterprise-grade site reliability engineering, today announced $120 million in new funding with a $1 billion valuation. The funding will support the company’s vision of extending AI across the software development lifecycle (SDLC) by making production systems more resilient. “Site reliability engineering is one of the hardest problems in applied AI because every company’s software environment is different, and with do...
-
SEMCO Technologies: Publication du nombre d’actions composant le capital social et du nombre total de droits de vote
CASTRIES, France--(BUSINESS WIRE)--Regulatory News: SEMCO Technologies (Code ISIN : FR0014010H01 : Mnémonique : ALSEM), entreprise spécialisée dans la conception et la fabrication de composants stratégiques pour la production de semi-conducteurs, publie aujourd’hui le nombre d’actions composant le capital social et le nombre total de droits de vote au 31 octobre 2026. Date Nombre total d'actions composant le capital Nombre total de droits de vote théoriques* Nombre total de droits de vote exerç...
-
OOG and STAT Announce Strategic Content Partnership to Bring Trusted Journalism to Clinicians
SANTA MONICA, Calif.--(BUSINESS WIRE)--OOG and STAT Announce Strategic Content Partnership to Bring Trusted Journalism to Clinicians...